Lotus Pharmaceutical Discontinued
FDA Approved Drugs

Lotus Pharmaceutical Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 12
  • Latest Approval Date Apr 23, 2021
  • Data Source FDA
  • First Approval Date Nov 05, 2010
All
13
View
Unclassified
1
View
Discontinued
12
View
Company Overview

Company

Lotus Pharmaceutical Discontinued

Country

Taiwan

Website

Visit Website

Email

Jasonhsu@lotuspharm.com

Social Profiles

LinkedIn
Company Snapshot

Lotus Pharmaceutical Discontinued

17F, No. 277, Song Ren Road, Xin Yi District, Taipei City 110

Taiwan

www.lotuspharm.com/ Jasonhsu@lotuspharm.com View on Map
FDA Approved Drug Records ( 12 records )
2016
26 Jul
Discontinued Application: 203298

Drug Name

CALCIUM ACETATE

Product Number

1

Dosage Form

-

Strength

667MG

Approval Date

2016-07-26

203298 / 1

Active Ingredient

CALCIUM ACETATE

Application Number

203298

Product Number

1

Dosage Form

-

Strength

667MG

Approval Date

2016-07-26

Regulatory Status

Discontinued

2010
05 Nov
Discontinued Application: 90906

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2010-11-05

90906 / 1

Active Ingredient

LEVETIRACETAM

Application Number

90906

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2010-11-05

Regulatory Status

Discontinued

2016
31 Oct
Discontinued Application: 90906

Drug Name

LEVETIRACETAM

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2016-10-31

90906 / 2

Active Ingredient

LEVETIRACETAM

Application Number

90906

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2016-10-31

Regulatory Status

Discontinued

2016
31 Oct
Discontinued Application: 90906

Drug Name

LEVETIRACETAM

Product Number

3

Dosage Form

-

Strength

750MG

Approval Date

2016-10-31

90906 / 3

Active Ingredient

LEVETIRACETAM

Application Number

90906

Product Number

3

Dosage Form

-

Strength

750MG

Approval Date

2016-10-31

Regulatory Status

Discontinued

2016
31 Oct
Discontinued Application: 90906

Drug Name

LEVETIRACETAM

Product Number

4

Dosage Form

-

Strength

1GM

Approval Date

2016-10-31

90906 / 4

Active Ingredient

LEVETIRACETAM

Application Number

90906

Product Number

4

Dosage Form

-

Strength

1GM

Approval Date

2016-10-31

Regulatory Status

Discontinued

2016
06 Jun
Discontinued Application: 202095

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

750MG

Approval Date

2016-06-06

202095 / 1

Active Ingredient

LEVETIRACETAM

Application Number

202095

Product Number

1

Dosage Form

-

Strength

750MG

Approval Date

2016-06-06

Regulatory Status

Discontinued

2016
06 Jun
Discontinued Application: 202095

Drug Name

LEVETIRACETAM

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2016-06-06

202095 / 2

Active Ingredient

LEVETIRACETAM

Application Number

202095

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2016-06-06

Regulatory Status

Discontinued

2016
02 Sep
Discontinued Application: 202684

Drug Name

LEVONORGESTREL

Product Number

1

Dosage Form

-

Strength

0.75MG

Approval Date

2016-09-02

202684 / 1

Active Ingredient

LEVONORGESTREL

Application Number

202684

Product Number

1

Dosage Form

-

Strength

0.75MG

Approval Date

2016-09-02

Regulatory Status

Discontinued

2021
23 Apr
Discontinued Application: 209787

Drug Name

METHOTREXATE SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2021-04-23

209787 / 1

Active Ingredient

METHOTREXATE SODIUM

Application Number

209787

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2021-04-23

Regulatory Status

Discontinued

2016
24 Feb
Discontinued Application: 206710

Drug Name

PARICALCITOL

Product Number

1

Dosage Form

-

Strength

1MCG

Approval Date

2016-02-24

206710 / 1

Active Ingredient

PARICALCITOL

Application Number

206710

Product Number

1

Dosage Form

-

Strength

1MCG

Approval Date

2016-02-24

Regulatory Status

Discontinued

2016
24 Feb
Discontinued Application: 206710

Drug Name

PARICALCITOL

Product Number

2

Dosage Form

-

Strength

2MCG

Approval Date

2016-02-24

206710 / 2

Active Ingredient

PARICALCITOL

Application Number

206710

Product Number

2

Dosage Form

-

Strength

2MCG

Approval Date

2016-02-24

Regulatory Status

Discontinued

2016
24 Feb
Discontinued Application: 206710

Drug Name

PARICALCITOL

Product Number

3

Dosage Form

-

Strength

4MCG

Approval Date

2016-02-24

206710 / 3

Active Ingredient

PARICALCITOL

Application Number

206710

Product Number

3

Dosage Form

-

Strength

4MCG

Approval Date

2016-02-24

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    13 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
12 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

CALCIUM ACETATE

Application Number

203298

Product Number

1

Active Ingredient

CALCIUM ACETATE

Dosage Form

-

Strength

667MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit